| 1 | suggest | 35,004 |
| 2 | agreed/agreed | 2 |
| 3 | revels | 2 |
| 4 | -doses | 1 |
| 5 | 1-phenyl-1,3-butadienes | 1 |
| 6 | 3-hydroxy-4-methoxybenzaldehyde | 1 |
| 7 | 32,850 | 1 |
| 8 | 55kd | 1 |
| 9 | 5806.83 | 1 |
| 10 | acidophilix | 1 |
| 11 | antipsychotics-have | 1 |
| 12 | bialaphos | 1 |
| 13 | c-ret | 1 |
| 14 | c/r | 1 |
| 15 | chromates | 1 |
| 16 | cldn2 | 1 |
| 17 | convention-and | 1 |
| 18 | coronaridine | 1 |
| 19 | gamma-secretases | 1 |
| 20 | ibd-and | 1 |
| 21 | impracticalities | 1 |
| 22 | inconvenients | 1 |
| 23 | indigenization | 1 |
| 24 | lphsfa1 | 1 |
| 25 | maculopathies | 1 |
| 26 | manheim | 1 |
| 27 | mirna* | 1 |
| 28 | mitigator | 1 |
| 29 | obtainedfromtwo | 1 |
| 30 | oxaliplatin/irinotecan | 1 |
| 31 | reveales | 1 |
| 32 | reveled | 1 |
| 33 | strategy-and | 1 |
| 34 | substrate/processes | 1 |
| 35 | tolerogens | 1 |
| 36 | us-expectancies | 1 |
| 37 | weight-for-length/bmi | 1 |
| 38 | whistles | 1 |
| 39 | wirings | 1 |
| 1 | -doses | 1 |
| 2 | 1-phenyl-1,3-butadienes | 1 |
| 3 | 3-hydroxy-4-methoxybenzaldehyde | 1 |
| 4 | 32,850 | 1 |
| 5 | 55kd | 1 |
| 6 | 5806.83 | 1 |
| 7 | acidophilix | 1 |
| 8 | agreed/agreed | 2 |
| 9 | antipsychotics-have | 1 |
| 10 | bialaphos | 1 |
| 11 | c-ret | 1 |
| 12 | c/r | 1 |
| 13 | chromates | 1 |
| 14 | cldn2 | 1 |
| 15 | convention-and | 1 |
| 16 | coronaridine | 1 |
| 17 | gamma-secretases | 1 |
| 18 | ibd-and | 1 |
| 19 | impracticalities | 1 |
| 20 | inconvenients | 1 |
| 21 | indigenization | 1 |
| 22 | lphsfa1 | 1 |
| 23 | maculopathies | 1 |
| 24 | manheim | 1 |
| 25 | mirna* | 1 |
| 26 | mitigator | 1 |
| 27 | obtainedfromtwo | 1 |
| 28 | oxaliplatin/irinotecan | 1 |
| 29 | reveales | 1 |
| 30 | reveled | 1 |
| 31 | revels | 2 |
| 32 | strategy-and | 1 |
| 33 | substrate/processes | 1 |
| 34 | suggest | 35,004 |
| 35 | tolerogens | 1 |
| 36 | us-expectancies | 1 |
| 37 | weight-for-length/bmi | 1 |
| 38 | whistles | 1 |
| 39 | wirings | 1 |
| 1 | mirna* | 1 |
| 2 | 32,850 | 1 |
| 3 | lphsfa1 | 1 |
| 4 | cldn2 | 1 |
| 5 | 5806.83 | 1 |
| 6 | agreed/agreed | 2 |
| 7 | reveled | 1 |
| 8 | 55kd | 1 |
| 9 | ibd-and | 1 |
| 10 | convention-and | 1 |
| 11 | strategy-and | 1 |
| 12 | 3-hydroxy-4-methoxybenzaldehyde | 1 |
| 13 | coronaridine | 1 |
| 14 | antipsychotics-have | 1 |
| 15 | weight-for-length/bmi | 1 |
| 16 | manheim | 1 |
| 17 | oxaliplatin/irinotecan | 1 |
| 18 | indigenization | 1 |
| 19 | obtainedfromtwo | 1 |
| 20 | c/r | 1 |
| 21 | mitigator | 1 |
| 22 | us-expectancies | 1 |
| 23 | maculopathies | 1 |
| 24 | impracticalities | 1 |
| 25 | reveales | 1 |
| 26 | whistles | 1 |
| 27 | 1-phenyl-1,3-butadienes | 1 |
| 28 | gamma-secretases | 1 |
| 29 | -doses | 1 |
| 30 | substrate/processes | 1 |
| 31 | chromates | 1 |
| 32 | wirings | 1 |
| 33 | revels | 2 |
| 34 | tolerogens | 1 |
| 35 | bialaphos | 1 |
| 36 | inconvenients | 1 |
| 37 | c-ret | 1 |
| 38 | suggest | 35,004 |
| 39 | acidophilix | 1 |